Is it too soon to eliminate quinine?

The Lancet Infectious Diseases

Volumn 10, Issue 3, 2010, Pages 141-142

  Barennes, Hubert ^a   Srour, Leila M ^b   Pussard, Eric ^c  

^a Institut de la Francophonie pour la Medecine Tropicale   (Laos)

^b UNIVERSITY OF HEALTH SCIENCES   (Laos)

^c BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ARTEMISININ; ARTESUNATE; QUININE;

AFRICA; AGRANULOCYTOSIS; COST EFFECTIVENESS ANALYSIS; CYTOLYSIS; DRUG COST; DRUG EFFICACY; DRUG TOLERABILITY; GEOGRAPHIC DISTRIBUTION; HEALTH CARE PERSONNEL; HUMAN; LETTER; MALARIA; MONOTHERAPY; PLASMODIUM FALCIPARUM; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SIDE EFFECT;

ADULT; AFRICA; ANTI-INFECTIVE AGENTS; ANTIMALARIALS; ARTEMISININS; CHILD; HUMANS; MALARIA; QUININE;

EID: 77149141780     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(10)70009-8     Document Type: Letter

References (10)

1. Yeka A., Achan J., D'Alessandro U., and Talisuna A.O. Quinine monotherapy for treating uncomplicated malaria in the era of artemisinin-based combination therapy: an appropriate public health policy?. Lancet Infect Dis 9 (2009) 448-452
2. Ramharter M., Wernsdorfer W.H., and Kremsner P.G. In vitro activity of quinolines against Plasmodium falciparum in Gabon. Acta Trop 90 (2004) 55-60
3. Praygod G., de Frey A., and Eisenhut M. Artemisinin derivatives versus quinine in treating severe malaria in children: a systematic review. Malar J 7 (2008) 210
4. Dondorp A., Nosten F., Stepniewska K., Day N., and White N. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet 366 (2005) 717-725
5. Day N., and Dondorp A.M. The management of patients with severe malaria. Am J Trop Med Hyg 77 suppl (2007) 29-35
6. WHO. World Malaria Report 2008 (2008), World Health Organization, Geneva. http://www.who.int/malaria/wmr2008/ (accessed July 2, 2009).
7. Neftel K.A., Woodtly W., Schmid M., Frick P.G., and Fehr J. Amodiaquine induced agranulocytosis and liver damage. BMJ 292 (1986) 721-723
8. Noeld H., Se Y., Schaeder K., Smith L.B., Socheat D., and Fukuda M. Evidence of artemisin-resistant malaria in western Cambodia. N Engl J Med 359 (2009) 2619-2620
9. Suwandittakul N., Chaijaroenkul W., Harnyuttanakorn P., Mungthin M., and Na B.K. Drug resistance and in vitro susceptibility of Plasmodium falciparum in Thailand during 1988-2003. Korean J Parasitol 47 (2009) 139-144
10. Chotivanich K., Sattabongkot J., Udomsangpetch R., et al. Transmission-blocking activities of quinine, primaquine, and artesunate. Antimicrob Agents Chemother 50 (2006) 1927-1930